Just in from @NEJM - Our case report on the use of anti-insulin receptor antibodies as a novel strategy to tackle refractory hypoglycemia and malignant insulinoma! Immensely grateful to my mentors ME Patti and Ahmed Rattani and the ICU & endocrine team @BIDMChealth as well as the

Thank you @Erman_Akkus for highlighting our MTAP study. Notably, we did not find association between OS & CDKN2A/B loss when MTAP was intact – raising an importance ❓ if CDKN2A/B mutations are bystanders and the biological roles of these 3 proteins in CCA progression @curecc.

RT @DeepaRangachari: Immensely proud of and grateful for this village! We gathered to celebrate intelligence, integrity, curiosity, and com….

Wrapped up heme/onc fellowship today —grateful and excited to stay on as a GI oncology attending at @BIDMChealth ! Sincere thanks to @DeepaRangachari and @rushadpatell for your wise counsel, impactful mentorship and unwavering support throughout the journey. 🙏🙏🙏

RT @ShrutiPatelMD: “Not everything that counts can be counted. Not everything that can be counted, counts.” -@marklewismd . In oncology, m….

RT @EricTopol: The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial @NEJM #ASCO25….

Thank you @melinda_bachini and @curecc for supporting my @ASCO YIA application and @ConquerCancerFd for funding our study to advance the understanding of cholangiocarcinoma tumor microenvironment. Incredibly grateful for the mentorship from the BI team ML peters, @ioavlachos and

RT @DeepaRangachari: @BIDMC_CancerCtr and @BIDMC_HOFellows are elated and proud to celebrate our very own senior fellow Dr. @alm_o for this….

RT @CMichaelGibson: Go here to sign the petition to #ShutDownMASS in order to minimize the spread of #coronavirus at .